keyword
https://read.qxmd.com/read/38663936/myeloid-derived-suppressor-cells-attenuate-the-antitumor-efficacy-of-radiopharmaceutical-therapy-using-90-y-nm600-in-combination-with-androgen-deprivation-therapy-in-murine-prostate-tumors
#21
JOURNAL ARTICLE
Anusha Muralidhar, Reinier Hernandez, Zachary S Morris, Hansel Comas Rojas, Malick Bio Idrissou, Jamey P Weichert, Douglas G McNeel
RATIONALE: Androgen deprivation therapy (ADT) is pivotal in treating recurrent prostate cancer and is often combined with external beam radiation therapy (EBRT) for localized disease. However, for metastatic castration-resistant prostate cancer, EBRT is typically only used in the palliative setting, because of the inability to radiate all sites of disease. Systemic radiation treatments that preferentially irradiate cancer cells, known as radiopharmaceutical therapy or targeted radionuclide therapy (TRT), have demonstrable benefits for treating metastatic prostate cancer...
April 24, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38659264/the-molecular-characteristics-and-therapeutic-implications-of-o-glycan-synthesis-in-pancreatic-cancer-by-integrating-transcriptome-and-single-cell-data
#22
JOURNAL ARTICLE
Binqian Huang, Biao Zhang, Jifeng Liu, Tingxin Wang, Yunshu Zhang, Bolin Zhang, Qihang Yuan, Shilin Xia, Dong Shang
BACKGROUND: Glycans constitute the primary components of proteins that regulate key carcinogenic processes in cancer progression. This study investigated the significance of O-glycan synthesis in the pathogenesis, outcome, and therapy of pancreatic cancer (PC). METHODS: Transcriptomic data and clinical prognostic information of PC were acquired via TCGA and GEO databases. CSA database was used to obtain single-cell data of PC. The O-glycan biosynthesis signaling pathway and its related genes were acquired via the MSigDB platform...
April 24, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38642938/dysregulation-of-cd4-and-cd8-resident-memory-t-myeloid-and-stromal-cells-in-steroid-experienced-checkpoint-inhibitor-colitis
#23
JOURNAL ARTICLE
Jun Yan He, Yang-Joon Kim, Elvira Mennillo, Iulia Rusu, Jared Bain, Arjun A Rao, Christopher Andersen, Karen Law, Hai Yang, Jessica Tsui, Alan Shen, Brittany Davidson, Divyashree Kushnoor, Yimin Shi, Frances Fan, Alexander Cheung, Li Zhang, Lawrence Fong, Alexis J Combes, Angela O Pisco, Michael G Kattah, David Y Oh
BACKGROUND: Colitis caused by checkpoint inhibitors (CPI) is frequent and is treated with empiric steroids, but CPI colitis mechanisms in steroid-experienced or refractory disease are unclear. METHODS: Using colon biopsies and blood from predominantly steroid-experienced CPI colitis patients, we performed multiplexed single-cell transcriptomics and proteomics to nominate contributing populations. RESULTS: CPI colitis biopsies showed enrichment of CD4+ resident memory (RM) T cells in addition to CD8+ RM and cytotoxic CD8+ T cells...
April 19, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38642912/disrupting-b-and-t-cell-collaboration-in-autoimmune-disease-t-cell-engagers-versus-car-t-cell-therapy
#24
JOURNAL ARTICLE
Kavina Shah, Maria Leandro, Mark Cragg, Florian Kollert, Franz Schuler, Christian Klein, Venkat Reddy
B and T cells collaborate to drive autoimmune disease (AID). Historically, B and T cell (B-T cell) co-interaction was targeted through different pathways such as alemtuzumab, abatacept, and dapirolizumab with variable impact on B cell depletion (BCD), whereas the majority of patients with AID including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and organ transplantation benefit from targeted BCD with anti-CD20 monoclonal antibodies such as rituximab, ocrelizumab or ofatumumab. Refractory AID is a significant problem for patients with incomplete BCD with a greater frequency of IgD-CD27+ switched memory B cells, CD19+CD20- B cells and plasma cells that are not directly targeted by anti-CD20 antibodies, whereas most lymphoid tissue plasma cells express CD19...
April 20, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38641183/lymph-node-targeting-strategy-using-a-hydrogel-sustained-release-system-to-load-effector-memory-t-cells-improves-the-anti-tumor-efficacy-of-anti-pd-1
#25
JOURNAL ARTICLE
Hao Cui, Yu-Yue Zhao, Yan-Hua Han, Zhou Lan, Ke-Long Zou, Guo-Wang Cheng, Hao Chen, Pei-Liang Zhong, Yan Chen, Li-Min Ma, Tong-Kai Chen, Guang-Tao Yu
Communication between tumors and lymph nodes carries substantial significance for antitumor immunotherapy. Remodeling the immune microenvironment of tumor-draining lymph nodes (TdLN) plays a key role in enhancing the anti-tumor ability of immunotherapy. In this study, we constructed a biomimetic artificial lymph node structure composed of F127 hydrogel loading effector memory T (TEM ) cells and PD-1 inhibitors (aPD-1). The biomimetic lymph nodes facilitate the delivery of TEM cells and aPD-1 to the TdLN and the tumor immune microenvironment, thus realizing effective and sustained anti-tumor immunotherapy...
April 17, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38640784/implantable-car-t-cell-factories-enhance-solid-tumor-treatment
#26
JOURNAL ARTICLE
Sharda Pandit, Pritha Agarwalla, Feifei Song, Anton Jansson, Gianpietro Dotti, Yevgeny Brudno
Chimeric Antigen Receptor (CAR) T cell therapy has produced revolutionary success in hematological cancers such as leukemia and lymphoma. Nonetheless, its translation to solid tumors faces challenges due to manufacturing complexities, short-lived in vivo persistence, and transient therapeutic impact. We introduce 'Drydux' - an innovative macroporous biomaterial scaffold designed for rapid, efficient in-situ generation of tumor-specific CAR T cells. Drydux expedites CAR T cell preparation with a mere three-day turnaround from patient blood collection, presenting a cost-effective, streamlined alternative to conventional methodologies...
April 15, 2024: Biomaterials
https://read.qxmd.com/read/38638445/phenotypic-immune-characterization-of-gastric-and-esophageal-adenocarcinomas-reveals-profound-immune-suppression-in-esophageal-tumor-locations
#27
JOURNAL ARTICLE
Tessa S Groen-van Schooten, Micaela Harrasser, Jens Seidel, Emma N Bos, Tania Fleitas, Monique van Mourik, Roos E Pouw, Ruben S A Goedegebuure, Benthe H Doeve, Jasper Sanders, Joris Bos, Mark I van Berge Henegouwen, Victor L J L Thijssen, Nicole C T van Grieken, Hanneke W M van Laarhoven, Tanja D de Gruijl, Sarah Derks
BACKGROUND: Tumors in the distal esophagus (EAC), gastro-esophageal junction including cardia (GEJAC), and stomach (GAC) develop in close proximity and show strong similarities on a molecular and cellular level. However, recent clinical data showed that the effectiveness of chemo-immunotherapy is limited to a subset of GEAC patients and that EACs and GEJACs generally benefit less from checkpoint inhibition compared to GACs. As the composition of the tumor immune microenvironment drives response to (immuno)therapy we here performed a detailed immune analysis of a large series of GEACs to facilitate the development of a more individualized immunomodulatory strategy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638044/il-7r-expression-correlates-with-prognosis-in-breast-cancer
#28
JOURNAL ARTICLE
Xiaojie Yu, Hao Zhang, Jing Liu, Changran Hou, Haojie Zhang, Zhenlin Yang
BACKGROUND: The tumor microenvironment (TME) exerts a significant influence on the development, invasion, metastasis, and drug resistance of breast cancer. Therefore, this study sought to investigate potential prognostic factors and markers indicative of TME remodeling in breast cancer, utilizing data from the TCGA database. METHODS: In this study, transcriptome RNA-seq data from 1222 breast cancer samples were processed using CIBERSORT and ESTIMATE algorithms. We conducted a differential gene expression analysis utilizing COX regression analysis and constructed protein-protein interaction (PPI) networks for enhanced visualization...
April 17, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38637990/bis-2-f-cg-s-a-s-mp-isomers-encapsulated-in-cytidinyl-cationic-lipids-act-as-potent-in-situ-autologous-tumor-vaccines
#29
JOURNAL ARTICLE
Jing Yu, Xiaotong Yu, Xudong Sun, Quanxin Wang, Sijie Long, Runan Ren, Zhu Guan, Zhenjun Yang
Cancer immunotherapy has greatly improved the prognosis of tumor-bearing patients. Nevertheless, cancer patients exhibit low response rates to current immunotherapy drugs, such as PD1 and PDL1 antibodies. Cyclic dinucleotide analogs are a promising class of immunotherapeutic agents. In this study, in situ autologous tumor vaccines, composed of Bis-2'-F-cGS AS MP phosphonothioate isomers (FGA-di-pS-2 or FGA-di-pS-4) and cytidinyl/cationic lipids (Mix), were constructed. Intravenous (i.v.) and intratumoral (i...
April 17, 2024: Molecular Therapy
https://read.qxmd.com/read/38637967/effector-function-characteristics-of-exhausted-cd8-t-cell-in-microsatellite-stable-and-unstable-gastric-cancer
#30
JOURNAL ARTICLE
Dong-Seok Han, Yoonjin Kwak, Seungho Lee, Soo Kyung Nam, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Nak-Jung Kwon, Hye Seung Lee, Han-Kwang Yang
PURPOSE: Gastric cancer exhibits molecular heterogeneity, with the microsatellite instability high (MSI-H) subtype drawing attention for its distinct features. Despite a higher survival rate, MSI-H gastric cancer lack significant benefits from conventional chemotherapy. The immune checkpoint inhibitors (ICIs), presents a potential avenue, but a deeper understanding of the tumor immune microenvironment of MSI-H gastric cancer is essential. MATERIALS AND METHODS: We explored the molecular characteristics of CD8+ T cell subtypes in three MSI-H and three microsatellite stable (MSS) gastric cancer samples using single-cell RNA sequencing and spatial transcriptome analysis...
April 12, 2024: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/38632596/tissue-resident-memory-t-cells-decoding-intra-organ-diversity-with-a-gut-perspective
#31
REVIEW
Mari Murakami
Tissue-resident memory T cells (TRM ) serve as the frontline of host defense, playing a critical role in protection against invading pathogens. This emphasizes their role in providing rapid on-site immune responses across various organs. The physiological significance of TRM is not just confined to infection control; accumulating evidence has revealed that TRM also determine the pathology of diseases such as autoimmune disorders, inflammatory bowel disease, and cancer. Intensive studies on the origin, mechanisms of formation and maintenance, and physiological significance of TRM have elucidated the transcriptional and functional diversity of these cells, which are often affected by local cues associated with their presence...
April 17, 2024: Inflammation and Regeneration
https://read.qxmd.com/read/38631710/b-cells-and-the-coordination-of-immune-checkpoint-inhibitor-response-in-patients-with-solid-tumors
#32
REVIEW
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucia Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, Francois-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
Immunotherapy profoundly changed the landscape of cancer therapy by providing long-lasting responses in subsets of patients and is now the standard of care in several solid tumor types. However, immunotherapy activity beyond conventional immune checkpoint inhibition is plateauing, and biomarkers are overall lacking to guide treatment selection. Most studies have focused on T cell engagement and response, but there is a growing evidence that B cells may be key players in the establishment of an organized immune response, notably through tertiary lymphoid structures...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38630265/expansion-of-tumor-infiltrating-lymphocytes-from-head-and-neck-squamous-cell-carcinoma-to-assess-the-potential-of-adoptive-cell-therapy
#33
JOURNAL ARTICLE
Sangjoon Choi, Mofazzal Hossain, Hyun Lee, Jina Baek, Hye Seon Park, Chae-Lyul Lim, DoYeon Han, Taehyun Park, Jong Hyeok Kim, Gyungyub Gong, Mi-Na Kweon, Hee Jin Lee
BACKGROUND: Adoptive transfer of in vitro expanded tumor-infiltrating lymphocytes (TILs) has been effective in regressing several types of malignant tumors. This study assessed the yield and factors influencing the successful expansion of tumor-infiltrating lymphocytes (TILs) from head and neck squamous cell carcinoma (HNSCC), along with their immune phenotypes. METHODS: TILs were expanded from 47 surgically resected HNSCC specimens and their metastasized lymph nodes...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630135/intratumor-injection-of-bcg-ag85a-high-affinity-peptides-enhanced-anti-tumor-efficacy-in-ppd-positive-melanoma
#34
JOURNAL ARTICLE
Lanqun Qin, Guiying Zhang, Yirong Wu, Yueling Yang, Zhengyun Zou
As one of the scheduled immunization vaccines worldwide, virtually all individuals have been vaccinated with BCG vaccine. In order to verify the hypothesis that delivering BCG high-affinity peptides to tumor areas could activate the existing BCG memory T cells to attack tumor, we firstly predicted the HLA-A*0201 high-affinity peptides of BCG Ag85A protein (KLIANNTRV, GLPVEYLQV), and then, A375 melanoma cells and HLA-A*0201 PBMCs (from PPD-positive adults) were added to co-incubated with the predicted peptides in vitro...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38628740/uncovering-a-novel-dna-repair-related-radiosensitivity-model-for-evaluation-of-radiotherapy-susceptibility-in-uterine-corpus-endometrial-cancer
#35
JOURNAL ARTICLE
Hainan Yang, Yanru Qiu, Junjun Chen, Jinzhi Lai
BACKGROUND: Uterine corpus endometrial cancer (UCEC) exhibit heterogeneity in their DNA repair capacity, which can impact their response to radiotherapy. Our study aimed to identify potential DNA repair-related biomarkers for predicting radiation response in UCEC. METHODS: We conducted a thorough analysis of 497 UCEC samples obtained from TCGA database. Using LASSO-COX regression analysis, we constructed a radiosensitivity signature and subsequently divided patients into the radiosensitive (RS) and the radioresistant (RR) groups based on their radiosensitivity index...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628547/a-lipid-plga-nanocomplex-to-reshape-tumor-immune-microenvironment-for-colon-cancer-therapy
#36
JOURNAL ARTICLE
Nan Zhang, Qiqi Sun, Junhua Li, Jing Li, Lei Tang, Quan Zhao, Yuji Pu, Gaofeng Liang, Bin He, Wenxia Gao, Jianlin Chen
Immune checkpoint blockade therapy provides a new strategy for tumor treatment; however, the insufficient infiltration of cytotoxic T cells and immunosuppression in tumor microenvironment lead to unsatisfied effects. Herein, we reported a lipid/PLGA nanocomplex (RDCM) co-loaded with the photosensitizer Ce6 and the indoleamine 2,3-dioxygenase (IDO) inhibitor 1MT to improve immunotherapy of colon cancer. Arginine-glycine-aspartic acid (RGD) as the targeting moiety was conjugated on 1,2-distearoyl-snglycero-3-phosphoethanolamine lipid via polyethylene glycol (PEG), and programmed cell death-ligand 1 (PD-L1) peptide inhibitor DPPA (sequence: CPLGVRGK-GGG-d(NYSKPTDRQYHF)) was immobilized on the terminal group of PEG via matrix metalloproteinase 2 sensitive peptide linker...
2024: Regenerative Biomaterials
https://read.qxmd.com/read/38623058/unraveling-the-heterogeneity-of-cd8-t-cell-subsets-in-liver-cirrhosis-implications-for-disease-progression
#37
JOURNAL ARTICLE
Kepu Zheng, Leiyang Dai, Shengning Zhang, Yingpeng Zhao, Wang Li, Yang Gao, Yuanyi Mang, Lingfeng Jiao, Yu Tang, Jianghua Ran
BACKGROUND/AIMS: : Liver cirrhosis involves chronic inflammation and progressive fibrosis. Among various immune cells, CD8+ T cells are considered a major contributor to hepatic inflammation and fibrosis. However, the exact molecular pathways governing CD8+ T-cell-mediated effects in cirrhosis remain unclear. METHODS: : This study analyzed transcriptomic and single-cell sequencing data to elucidate CD8+ T-cell heterogeneity and implications in cirrhosis. RESULTS: : Weighted gene co-expression analysis of bulk RNA-seq data revealed an association between cirrhosis severity and activated T-cell markers like HLA and chemokine genes...
April 16, 2024: Gut and Liver
https://read.qxmd.com/read/38622392/posttranscriptional-events-orchestrate-immune-homeostasis-of-cd8-t-cells
#38
JOURNAL ARTICLE
Julian J Freen-van Heeren
Maintaining immune homeostasis is instrumental for host health. Immune cells, such as T cells, are instrumental for the eradication of pathogenic bacteria, fungi and viruses. Furthermore, T cells also play a major role in the fight against cancer. Through the formation of immunological memory, a pool of antigen-experienced T cells remains in the body to rapidly protect the host upon reinfection or retransformation. In order to perform their protective function, T cells produce cytolytic molecules, such as granzymes and perforin, and cytokines such as interferon γ and tumor necrosis factor α...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38622289/exploring-the-immunomodulatory-potential-of-brahmi-bacopa-monnieri-in-the-treatment-of-invasive-ductal-carcinoma
#39
JOURNAL ARTICLE
Sohini Roy, Geetha Shanmugam, Sudeshna Rakshit, R Pradeep, Melvin George, Koustav Sarkar
Bacopa monnieri (L) Wettst, commonly known as Brahmi, stands as a medicinal plant integral to India's traditional medical system, Ayurveda, where it is recognized as a "medhya rasayana"-a botanical entity believed to enhance intellect and mental clarity. Its significant role in numerous Ayurvedic formulations designed to address conditions such as anxiety, memory loss, impaired cognition, and diminished concentration underscores its prominence. Beyond its application in cognitive health, Brahmi has historically been employed in Ayurvedic practices for the treatment of inflammatory diseases, including arthritis...
April 15, 2024: Medical Oncology
https://read.qxmd.com/read/38622286/blockade-of-tgf-%C3%AE-and-pd-l1-by-bintrafusp-alfa-promotes-survival-in-preclinical-ovarian-cancer-models-by-promoting-t-effector-and-nk-cell-responses
#40
JOURNAL ARTICLE
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W Craig
BACKGROUND: Failure of immunotherapy in high-grade serous ovarian cancer (HGSC) may be due to high levels of transforming growth factor-β (TGF-β) in ascites or tumour immune microenvironment (TIME). Here, we test whether coordinated blockade of TGF-β and PD-L1 with bintrafusp alfa (BA) can provoke anti-tumour immune responses in preclinical HGSC models. METHODS: BA is a first-in-class bifunctional inhibitor of TGF-β and PD-L1, and was tested for effects on overall survival and altered TIME in syngeneic HGSC models...
April 15, 2024: British Journal of Cancer
keyword
keyword
109581
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.